Ignite Creation Date:
2024-05-06 @ 6:18 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05618301
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2022-11-08
Brief Title:
Motixafortide and Natalizumab to Mobilize CD34 Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease SCD
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-08
First Submit QC Date:
November 8 2022
Study First Post Date:
2022-11-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL